Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death

Thrombolytic and Anticoagulant Therapy for Pulmonary Embolism with High and Intermendiate Risk of Early Death. Part 3. An Effect on Pulmonary Perfusion with High and Intermediate Risk of Early Death

Background The advantage of thrombolytic therapy (TLT) over anticoagulant therapy(ACT) in patients with a high risk of early death (hemodynamic disorders) in acute pulmonary embolism is considered proven. But the advantage of thrombolytic therapy over anticoagulant therapy remains uncertain in patie...

Full description

Saved in:
Bibliographic Details
Main Authors: O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, A. G. Dorfman, V. I. Avfukov
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2018-11-01
Series:Неотложная медицинская помощь
Subjects:
pulmonary embolism
thrombolytic therapy
anticoagulant therapy
perfusion scintigraphy
pulmonary perfusion deficiency
pulmonary hypertension
intermediate risk of early death
Online Access:https://www.jnmp.ru/jour/article/view/501
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jnmp.ru/jour/article/view/501

Similar Items